Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 100.00% is in line with its 5-year average of 93.63%, near the low end of its 5-year range (-26.89%–1140.89%).
8.19% above its 12-month average of 92.43%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 62.14%.
GROSS MARGIN
100.00%
GROSS MARGIN AVG TTM
92.43%
GROSS MARGIN AVG 3Y
100.00%
GROSS MARGIN AVG 5Y
93.63%
GROSS MARGIN AVG 10Y
86.42%
GROSS MARGIN AVG 15Y
83.36%
GROSS MARGIN AVG 20Y
80.26%
CURRENT VS TTM AVG
+8.19%
CURRENT VS 3Y AVG
0.00%
CURRENT VS 5Y AVG
+6.81%
CURRENT VS 10Y AVG
+15.72%
CURRENT VS 15Y AVG
+19.95%
CURRENT VS 20Y AVG
+24.59%
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+141.66%
vs the sector median at left
TherapeuticsMD, Inc.
Market Cap
$23.26M
Gross Margin
100.00%
TTM Avg
92.43%
3Y Avg
100.00%
5Y Avg
93.63%
Market Cap
$22.92M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$24.59M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$24.91M
Gross Margin
0.00%
TTM Avg
49.92%
3Y Avg
18.04%
5Y Avg
44.48%
Market Cap
$22.13M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$22.00M
Gross Margin
63.95%
TTM Avg
66.50%
3Y Avg
67.57%
5Y Avg
61.13%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | $23.26M | 100.00% | 92.43% | 100.00% | 93.63% |
| Kyntra Bio, Inc. (KYNB)vs › | $23.88M | 91.37% | 69.42% | 78.99% | 53.34% |
| Rein Therapeutics Inc. (RNTX)vs › | $22.92M | 0.00% | 0.00% | 0.00% | 0.00% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.59M | 0.00% | 0.00% | 0.00% | 0.00% |
| LeonaBio, Inc. (LONA)vs › | $22.20M | 0.00% | 0.00% | 0.00% | 0.00% |
| ABVC BioPharma, Inc. (ABVC)vs › | $24.91M | 0.00% | 49.92% | 18.04% | 44.48% |
| Modular Medical, Inc. (MODD)vs › | $22.13M | 0.00% | 0.00% | 0.00% | 0.00% |
| InspireMD, Inc. (NSPR)vs › | $25.30M | 29.50% | 25.49% | 25.43% | 20.30% |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.00M | 63.95% | 66.50% | 67.57% | 61.13% |
| iTonic Holdings Ltd. (ITOC)vs › | $25.78M | 62.59% | 69.78% | 74.14% | 76.12% |
Gross Margin
100.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 62.14% |
| 2026-03-31 | 100.00% |
| 2025-12-31 | 100.00% |
| 2025-09-30 | 100.00% |
| 2025-06-30 | 100.00% |
| 2025-03-31 | 100.00% |
| 2024-12-31 | 100.00% |
| 2024-09-30 | 100.00% |
| 2024-06-30 | 100.00% |
| 2024-03-31 | 100.00% |
| 2023-12-31 | -26.89% |
| 2023-09-30 | 100.00% |
| 2023-06-30 | 100.00% |
| 2023-03-31 | 100.00% |
| 2022-12-31 | 1140.89% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 74.64% |
| 2021-09-30 | 79.21% |
| 2021-06-30 | 82.04% |
| 2021-03-31 | 76.41% |
| 2020-12-31 | 75.28% |
| 2020-09-30 | 83.05% |
| 2020-06-30 | 58.88% |
| 2020-03-31 | 77.84% |
| 2019-12-31 | 81.90% |
| 2019-09-30 | 93.91% |
| 2019-06-30 | 79.46% |
| 2019-03-31 | 80.67% |
| 2018-12-31 | 81.32% |
| 2018-09-30 | 79.87% |
| 2018-06-30 | 87.93% |
| 2018-03-31 | 83.21% |
| 2017-12-31 | 85.58% |
| 2017-09-30 | 84.14% |
| 2017-06-30 | 83.96% |
| 2017-03-31 | 83.45% |
| 2016-12-31 | 84.18% |
| 2016-09-30 | 77.65% |
| 2016-06-30 | 74.33% |
| 2016-03-31 | 77.52% |
| 2015-12-31 | 78.05% |
| 2015-09-30 | 77.00% |
| 2015-06-30 | 78.69% |
| 2015-03-31 | 76.68% |
| 2014-12-31 | 79.34% |
| 2014-09-30 | 74.47% |
| 2014-06-30 | 76.20% |
| 2014-03-31 | 70.65% |
| 2013-12-31 | 83.68% |
| 2013-09-30 | 71.74% |
| 2013-06-30 | 77.72% |
| 2013-03-31 | 75.26% |
| 2012-12-31 | 73.18% |
| 2012-09-30 | 70.39% |
| 2012-06-30 | 54.54% |
| 2012-03-31 | 53.43% |
| 2011-12-31 | 54.60% |
| 2011-09-30 | 55.21% |
| 2011-06-30 | 52.99% |
| 2011-03-31 | 58.06% |
| 2010-12-31 | -58.93% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 100.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 69.38% |
| 2007-06-30 | 72.14% |
| 2007-03-31 | 66.10% |
| 2006-12-31 | 95.31% |
| 2006-09-30 | 80.08% |
| 2006-06-30 | 73.43% |
| 2006-03-31 | 71.77% |
| 2005-12-31 | 77.59% |
| 2005-09-30 | 81.82% |
| 2005-06-30 | 41.57% |
| 2005-03-31 | 76.00% |
| 2004-12-31 | 94.12% |
| 2004-09-30 | 62.30% |
| 2004-06-30 | 49.45% |
| 2004-03-31 | 72.77% |
| 2003-12-31 | 72.64% |
| 2003-09-30 | 66.21% |
| 2003-06-30 | 69.58% |
| 2003-03-31 | 71.16% |
| 2002-12-31 | 71.69% |
| 2002-09-30 | 71.88% |
